Summit Therapeutics Inc. SMMT
- ivonescimab — Non-Small Cell Lung Cancer Phase 3
- ivonescimab — Colorectal Cancer Phase 3
- ivonescimab — Head and Neck Squamous Cell Carcinoma Phase 3
VEGF-A (3 companies · 6 programs)
Companies with an active program directed at VEGF-A.
4D Molecular Therapeutics, Inc. FDMT
- 4D-150 — Wet Age-Related Macular Degeneration Phase 3
- 4D-150 — Diabetic Macular Edema Phase 2
NovaBridge Biosciences NBP
- VIS-101 — Wet Age-Related Macular Degeneration Phase 2